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Abstract
   Staphylococcus aureus ISP447, in its resistance to macrolide-lincosamide-streptogramin type B (MLSB) 
antibiotics, is induced in the presence of the 14-membered ring macrolides.  First, it was tested for qualitative 
inducible resistance using the disk diffusion method.  As a result, azithromycin of 15-membered ring macrolide with 
both clarithromycin and erythromycin, which belongs to the 14-membered ring macrolide, has an induced resistance 
to MLSB drugs.  However, ketolides such as telithromycin belonging to the 14-membered ring macrolide in this strain, 
does not induce resistance to MLSB antibiotics. 
   This study has investigated quantitatively resistant derivatives of 14-membered and 15-membered ring 
macrolides and ketolides using Staphylococcus aureus ISP447.  It is possible to analyze the structure-activity 
relationship between the inducibility of resistance to MLSB drugs and the chemical structure of the antimicrobial 
agents by using the quantitative results.  Measurement of the minimum inhibitory concentration (MIC) was obtained 
using the checkerboard method by broth microdilution method.  FIC index is an indicator to test the interaction 
between the two drugs from the MIC values which were determined using the checkerboard method.  Multiple 
regression analysis was used to obtained the partial regression coefficients using, for the purpose variable, the FIC 
index and explanatory variable substituent of the common lactone ring.  As a result, the substituent at the 3-position 
of the lactone ring macrolide, which is a common structure, has contributed most to the induction of resistance. 
Multiple correlation coefficient indicated the contribution rate was very high at 0.9353.  Therefore, the results of this 





















 MLSB誘導型耐性を示す Staphylococcus aureus 
ISP447を用いた。 
2.2 抗菌薬 
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